Molecular Signatures in Inflammatory Skin Disease
This research project aims to understand skin conditions like eczema (atopic dermatitis) and psoriasis better. We're looking at how people's bodies change at a very detailed level when they receive modern treatments like biologics. By studying genes, cells, and other body signals, we hope to find unique patterns that tell us why some treatments work well for certain individuals and not others. The goal is to gather information that will eventually help doctors recommend the most effective treatment for each patient based on their specific body responses. This could lead to more personalised and successful care for inflammatory skin diseases.
At a glance
What is this study about?
Imagine your skin has an ongoing battle where your immune system is a bit overactive, causing conditions like eczema (atopic dermatitis) or psoriasis. These conditions can be really uncomfortable, with red, itchy, or scaly patches.
Doctors have new medicines, often called 'biologics', which are very clever and target specific parts of the immune system to calm things down. But even with these advanced treatments, it's not always easy to know exactly which biologic will work best for each individual. What works wonders for one person might not be as effective for another. This study is like a detective trying to figure out these mysteries.
We're looking deep into people's bodies, examining their skin and blood at a tiny level to see how these medicines affect them. By collecting lots of detailed information – from different types of cells to genes – we aim to find 'molecular signatures'. Think of these as unique patterns or fingerprints that could tell us what's happening inside. If we can link these patterns to how well a treatment works, doctors could one day use this information to choose the perfect medicine for your specific type of eczema or psoriasis, leading to much better and more personalised care.
Key takeaways
- Aims to understand eczema and psoriasis better at a tiny, body-level.
- Studies how new biologic medicines affect your body's cells and genes.
- Hopes to find patterns that predict which treatment works best for different people.
- Could lead to more personalised and effective treatments in the future.
- Involves providing blood and skin samples while on your usual prescribed biologic medicine.
Who may be eligible?
This study is looking for adults who have already been diagnosed with a long-lasting inflammatory skin condition like eczema or psoriasis by a skin specialist (dermatologist). You would need to be currently receiving or about to start treatment with a specific type of modern medicine called a biologic, which your doctor has prescribed as part of your usual care.
To join, you must be able to understand the study information and give your written permission to take part, and you need to be able to follow the study instructions carefully. Your doctor will help determine if the specific biologic medicine you are taking or about to take is suitable for the study.
You wouldn't be able to join if you've recently used other strong immune-system medicines or light therapy (phototherapy) in the last four weeks. Also, if you've used certain creams or ointments (like strong steroid creams or calcineurin inhibitors) on the skin areas being looked at within a week before your first visit, you wouldn't be eligible. The study is open to both men and women of any age.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do I have eczema (atopic dermatitis) or psoriasis?
- Has my skin specialist (dermatologist) diagnosed my condition?
- Am I taking or about to start a biologic medicine for my condition?
- Can I understand the study information and give written permission to take part?
- Have I avoided other immune-system medicines or light therapy in the last 4 weeks?
- Have I avoided strong creams on the study area in the last 1 week?
What does participation involve?
As this is an exploratory study, the exact details of your participation might vary, but generally, it involves providing samples of your skin and blood at several points in time. You would continue receiving your prescribed biologic medicine as usual. Each time you visit, samples would be collected for detailed analysis. The researchers would look at these samples to see how your body is responding to the treatment at a very detailed level. This might involve collecting samples over a shorter period, possibly around the time you start your new medication and as your condition changes. The total duration of your participation would depend on how frequently samples are needed and for how long, which isn't specified but typically for such pilot studies, it might range from a few weeks to a few months to track initial responses.
Potential risks and benefits
Locations (1)
- Department of Dermatology, University Hospital Schleswig Holstein, Campus KielVerified postcodeKiel, Germany· Recruiting
Common questions
What kind of skin conditions are you studying?
We are looking at long-lasting inflammatory skin conditions such as eczema (atopic dermatitis) and psoriasis.
What are 'biologics'?
Biologics are a type of advanced medicine that target specific parts of your immune system to help reduce inflammation in conditions like eczema and psoriasis.
Will I get a new medicine in this study?
No, you will receive the biologic medicine that your doctor has already prescribed for your usual care. This study just observes how your body responds to it.
What kind of samples will be collected?
We will be collecting small samples of your blood and skin for detailed analysis.
How long will I be in the study?
The exact duration isn't specified, but it involves providing samples at different times, likely over several weeks or months, to track your body's response to treatment.
How to find out more
Stephan Weidinger, MD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.